Navigation Links
West Nile virus studies show how star-shaped brain cells cope with infection
Date:3/31/2009

A new study published as the cover article for the April 2009 issue of The FASEB Journal (http://www.fasebj.org) promises to give physicians new ways to reduce deadly responses to viral infections of the brain and spinal cord. In the report, scientists from Columbia University, NY, detail for the first time the chemical processes that star-shaped nerve cells, called astrocytes, use to handle invading viruses and to summon other immune cells to cause life-threatening inflammation.

"Studies such as this take us one step closer to understanding both the risk and benefit associated with antiviral immune response and may lead to new treatment strategies," said W. Ian Lipkin, the senior researcher involved in the study, who also is the director of Columbia's Center for Infection and Immunity, and led the team that first identified the presence of West Nile Virus in New York in 1999.

In this study, Lipkin and colleagues cultured astrocytes from the brains of newborn mice and exposed the cells to a West Nile virus-like molecule (called Poly I:C), either from outside or inside the brain cell membranes. After various laboratory experiments, the researchers identified the cellular machinery (such as a protein called MDA-5) that astrocytes use to "see" viral invaders. They also identified recognition molecules on the astrocytes that initiate and control the central nervous system's immune responses.

"Ironically, the cells we use to monitor and to protect out brainthe astrocytesare among those we know the least about," said Gerald Weissmann, M.D., editor-in-chief of The FASEB Journal. "We do know, however, that inflammation of the brain caused by the West Nile virus affects these star-shaped cells and makes the disease difficult to treat .We can use this new understanding of astrocytes not only to devise treatments for viral invaders from abroad, but also from deadly viruses closer to home.


'/>"/>

Contact: Cody Mooneyhan
cmooneyhan@faseb.org
301-634-7104
Federation of American Societies for Experimental Biology
Source:Eurekalert

Related biology news :

1. Catching the common cold virus genome
2. Epstein-Barr virus may be associated with progression of MS
3. Frogs immune system is key in fight against killer virus
4. Scientists identify human monoclonal antibodies effective against bird and seasonal flu viruses
5. Scientists identify human monoclonal antibodies effective against bird, seasonal flu viruses
6. Herpes virus: To vaccinate or not to vaccinate
7. Scripps scientists create first crystal structure of an intermediate particle in virus assembly
8. New vaccine developed for preventing uncommon cold virus
9. Viruses, start your engines!
10. Biologists learn structure, mechanism of powerful molecular motor in virus
11. Single virus used to convert adult cells to embryonic stem cell-like cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... -- Der weltweite Biobanking-Sektor wird bis zum ... mit mehr als 50 Vertretern aus verschiedenen Branchen wurde aber ... diese Prognose zu realisieren. ... Zu den Schwierigkeiten für ... für die Biobank, die Implementierung Zeit sparender Technologien, ein ...
(Date:2/13/2017)... Former 9/11 Commission border counsel and Special Counsel to ... of Identity Strategy Partners, LLP, today releases the following ... Protecting the Nation From Foreign Terrorist Entry Into the ... Trump,s ,Travel Ban, Executive Order gains more notoriety and ... ban, it is important that our national discourse regain ...
(Date:2/8/2017)... Inc. (NASDAQ: AWRE ), a leading supplier of ... quarter and year ended December 31, 2016. ... compared to $6.9 million in the same quarter last year. ... million compared to $2.6 million in the fourth quarter of ... $0.5 million, or $0.02 per diluted share, which compares to ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... Feb. 24, 2017 Provectus Biopharmaceuticals, Inc. ... "Company"), a clinical-stage oncology and dermatology biopharmaceutical company, ... to participate in its previously announced rights offering ... shares of common stock and Series C Convertible ... listed warrants. As previously announced, ...
(Date:2/24/2017)... 24, 2017 Symic Bio, a biopharmaceutical company ... category of therapeutics, announced today the completion of enrollment ... artery disease. The trial will evaluate the safety and ... the reduction of restenosis following angioplasty. ... for SB-030," said Nathan Bachtell , M.D., Chief ...
(Date:2/24/2017)... Blood Corporation (NYSE: CO ) ("CCBC" or ... laboratory testing, hematopoietic stem cell processing and stem cell ... the third quarter and first nine months of fiscal ... Quarter of Fiscal 2017 Highlights Revenues ... 18.6% to RMB200.9 million ($28.9 million). ...
(Date:2/24/2017)... Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), ... announced its financial results for the fourth quarter and fiscal ... Highlights Total sales in the fourth ... increased by 13.6% in USD terms to $77.6 million from ... Gross profit increased by 13.3% to $46.8 million from ...
Breaking Biology Technology: